Filing Flows › Opus Genetics (IRD) › Q2 2026 › vs Q2 2025
Opus Genetics (IRD) Q2 2026 vs Q2 2025 (year over year)
Opus Genetics's revenue fell $2.1M (-74%) from $2.9M in Q2 2025 to $755K in Q2 2026.
Opus Genetics, Q2 2026: revenue $755K (-74% year over year), net loss $8.1M, operating cash flow −$11.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $755K | $2.9M | −$2.1M | -74% |
| Other income, net | $8.4M | $1.5M | $6.9M | +464% |
| Net loss | $8.1M | $7.4M | $678K | +9% |
| Costs & expenses | $17.2M | $11.8M | $5.4M | +46% |
| Operating costs | $17.2M | $11.8M | $5.4M | +46% |
| Research & development | $11.2M | $6.0M | $5.2M | +86% |
| General & admin | $6.0M | $5.8M | $262K | +5% |
| Operating cash sources | $13.4M | $11.2M | $2.2M | +20% |
| Depreciation | $14K | $14K | $0 | 0% |
| Share-based compensation | $1.4M | $896K | $511K | +57% |
| Cash used in operations | $11.9M | $10.3M | $1.7M | +16% |
| Net loss absorbed | $8.1M | $7.4M | $678K | +9% |
| Working capital & other | $5.3M | $3.8M | $1.5M | +40% |
Questions
How much did Opus Genetics's revenue grow year over year in Q2 2026?
Opus Genetics's revenue fell $2.1M (-74%) from $2.9M in Q2 2025 to $755K in Q2 2026.